FDA

Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture

2025-01-15 00:00:00 +0000 UTC | Importance: 9/10

Dr. Patrizia Cavazzoni, former head of the FDA’s Center for Drug Evaluation and Research (CDER), immediately transitioned to Pfizer as chief medical officer, reigniting intense debate about the pharmaceutical industry’s regulatory influence and the problematic ‘revolving …

Patrizia Cavazzoni FDA Pfizer Robert F. Kennedy Jr. Center for Drug Evaluation and Research +2 more regulatory-capture pharmaceutical-industry fda revolving-door institutional-corruption +2 more

FDA Commissioner Califf's Pharmaceutical Industry Revolving Door Scrutinized

2024-09-20 00:00:00 +0000 UTC | Importance: 8/10

FDA Commissioner Robert Califf faces ongoing criticism for his extensive pharmaceutical industry ties. Having received over $8 million from drug companies and worked as a consultant for major pharmaceutical firms, Califf pledged to extend post-employment restrictions from 2 to 4 years to mitigate …

Robert Califf FDA Verily Life Sciences Joe Manchin Bernie Sanders regulatory-capture pharmaceutical-industry fda corporate-influence government-ethics

Joe Rogan Announces He Treated COVID with Unproven Ivermectin, Sparking Medical Misinformation Controversy

2021-09-01 00:00:00 +0000 UTC | Importance: 8/10

Podcaster Joe Rogan revealed he contracted COVID-19 and treated himself with ivermectin, a veterinary anti-parasitic drug not approved for COVID treatment, amplifying dangerous medical misinformation to his massive audience of 11 million listeners. The incident led to significant public health …

Joe Rogan Spotify The Joe Rogan Experience FDA Dr. Anthony Fauci +2 more covid-misinformation ivermectin medical-misinformation podcast-influence public-health +2 more

FDA Commissioner Stephen Hahn Joins Flagship Pioneering, Venture Firm Behind Moderna

2021-06-16 00:00:00 +0000 UTC | Importance: 9/10

Dr. Stephen Hahn, former FDA Commissioner who led the agency during COVID-19 vaccine emergency use authorizations, joined Flagship Pioneering as Chief Medical Officer on June 16, 2021. The move came six months after the FDA granted emergency use authorization to Moderna’s COVID-19 vaccine. …

Stephen Hahn Flagship Pioneering Moderna FDA regulatory-capture pharmaceutical-industry conflict-of-interest covid-pandemic fda-oversight

Former FDA Commissioner Scott Gottlieb Joins Pfizer Board After 3-Month Gap

2019-06-27 00:00:00 +0000 UTC | Importance: 8/10

Pfizer announced that Dr. Scott Gottlieb, who served as FDA Commissioner from May 2017 to April 2019, would join the pharmaceutical giant’s board of directors as an independent member. The appointment came just 85 days after Gottlieb resigned from the FDA, raising immediate concerns about …

Dr. Scott Gottlieb FDA Pfizer Senator Elizabeth Warren regulatory-capture fda pharmaceuticals revolving-door board-appointment +1 more

FDA Statistician Joan Buenconsejo Joins AstraZeneca After Overseeing Company Drug Reviews

2014-06-01 00:00:00 +0000 UTC | Importance: 7/10

Joan Buenconsejo, who led FDA analysis of medical statistics for drug reviews including AstraZeneca products in 2012-2013, joined AstraZeneca as a director and biometrics team leader in June 2014. This transition exemplifies the systemic ‘revolving door’ problem in pharmaceutical …

Joan Buenconsejo FDA AstraZeneca Center for Drug Evaluation and Research regulatory-capture pharmaceutical-industry fda revolving-door conflict-of-interest

FDA Arthritis Drug Reviewer Jeffrey Siegel Joins Genentech After Approving Company Tocilizumab

2010-12-15 00:00:00 +0000 UTC | Importance: 7/10

Jeffrey Siegel, an FDA staff member specializing in arthritis drug reviews, oversaw the 2010 approval of Genentech tocilizumab (Actemra) for arthritis treatment. Within months of the approval, Siegel left the FDA to join Genentech and its parent company Roche as director of the division that …

Jeffrey Siegel FDA Genentech Roche Actemra regulatory-capture pharmaceutical-industry fda revolving-door drug-approval

Purdue Reformulates OxyContin as "Abuse-Deterrent" After 14 Years, Drives Users to Heroin

2010-04-05 00:00:00 +0000 UTC | Importance: 8/10

On April 5, 2010, the FDA approved Purdue Pharma’s reformulated OxyContin designed to make it more difficult to crush, snort, or inject—14 years after the original drug’s launch and three years after the company’s guilty plea to criminal misbranding. Purdue ceased shipping the old …

Purdue Pharma FDA Sackler Family opioid-crisis pharmaceutical-industry regulatory-failure public-health unintended-consequences

FDA Whistleblower David Graham Testifies on Vioxx Cover-up Before Senate

2004-11-18 00:00:00 +0000 UTC | Importance: 9/10

FDA epidemiologist Dr. David Graham delivered explosive testimony before the U.S. Senate Finance Committee, declaring that ’the FDA, as currently configured, is incapable of protecting America against another Vioxx. We are virtually defenseless.’ Graham revealed that his study showed …

Dr. David Graham FDA Merck U.S. Senate Finance Committee Government Accountability Project regulatory-capture fda pharmaceuticals whistleblower vioxx +2 more

Opioid Epidemic Death Toll Reaches 500,000 Americans Between 2000-2020

2000-01-01 00:00:00 +0000 UTC | Importance: 10/10

Between 2000 and 2020, approximately 500,000 Americans died from opioid-involved overdoses, representing one of the most devastating preventable public health catastrophes in American history. The death toll resulted from a combination of aggressive pharmaceutical marketing, regulatory capture, and …

Purdue Pharma Sackler Family FDA DEA Pharmaceutical Industry opioid-crisis public-health-catastrophe mass-death regulatory-failure accountability-failure

FDA Approves OxyContin with Unsubstantiated Safety Claims

1995-12-20 00:00:00 +0000 UTC | Importance: 9/10

The FDA approved Purdue Pharma’s OxyContin application, including a scientifically unsubstantiated claim that delayed absorption ‘is believed to reduce the abuse liability of a drug.’ This approval occurred without clinical trials to prove the safety claim and marked the beginning …

FDA Purdue Pharma Dr. Curtis Wright Sackler Family regulatory-capture fda pharmaceuticals opioid-crisis revolving-door +1 more